advertisement
Huang Y 38
Showing records 1 to 25 |
Display all abstracts from Huang Y80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axisGong B
Genetics in Medicine 2019; 21: 2345-2354
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-AnalysisLiu Y
Frontiers in pharmacology 2019; 10: 679
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature reviewKumar A
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axisZhang H
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature reviewZastrow DB
American Journal of Medical Genetics, Part A 2019; 179: 966-977
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-AnalysisZhao J
Frontiers in pharmacology 2019; 10: 679
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature reviewKravets EJ
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axisHuang L
Genetics in Medicine 2019; 21: 2345-2354
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-AnalysisZhong X; Wei Q
Frontiers in pharmacology 2019; 10: 679
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature reviewBeleford D
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axisChen Y
Genetics in Medicine 2019; 21: 2345-2354
81416 Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-AnalysisHuang Y
Frontiers in pharmacology 2019; 10: 679
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature reviewRuzhnikov MRZ
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axisShi Y; Tam PO
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature reviewGrove ME
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axisZhu X
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature reviewDries AM
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axisHuang Y
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature reviewKohler JN; Waggott DM
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axisLei B; Sundaresan P
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature reviewYang Y
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axisLi X
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature reviewHuang Y;
American Journal of Medical Genetics, Part A 2019; 179: 966-977
80886 Mutant RAMP2 causes primary open-angle glaucoma via the CRLR-cAMP axisJiang L
Genetics in Medicine 2019; 21: 2345-2354
80748 Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature reviewMackenzie KM
American Journal of Medical Genetics, Part A 2019; 179: 966-977
Issue 20-3
Change Issue
advertisement